Richard J. Lewis
Corporate Officer/Principal en The University of Queensland .
Perfil
Richard J.
Lewis was the founder of Xenome Ltd.
which was founded in 2000, where he held the title of Chief Scientific Officer from 2000 to 2011.
Currently, he holds the title of Principal at The University of Queensland and National Health & Medical Research Council.
In the past, he held the title of Principal at Molecular Pharmacology (USA) Ltd.
Cargos activos de Richard J. Lewis
| Empresas | Cargo | Inicio |
|---|---|---|
| The University of Queensland | Corporate Officer/Principal | 01/07/2009 |
| National Health & Medical Research Council | Corporate Officer/Principal | 01/07/2009 |
Antiguos cargos conocidos de Richard J. Lewis.
| Empresas | Cargo | Fin |
|---|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Corporate Officer/Principal | - |
Xenome Ltd.
 Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MOLECULAR PHARMACOLOGY (USA), LTD. | Commercial Services |
| Empresas privadas | 2 |
|---|---|
Xenome Ltd.
Xenome Ltd. Pharmaceuticals: MajorHealth Technology Xenome Ltd. discovered and developed peptide pharmaceuticals. Its product, Xen2174, was a novel conopeptide analogue for the treatment of severe pain. The company was founded in 2008 and was headquartered in Indooroopilly, Australia. | Health Technology |
| National Health & Medical Research Council | Government |
- Bolsa de valores
- Insiders
- Richard J. Lewis